Larsen explains drug bills

Sixty people over age 60 gathered at Oak Harbor Senior Center Thursday to hear what Congressman Rick Larsen had to say about prescription drugs benefits and the future of Medicare. They also came to speak their mind.

They asked their Second District representative how the proposed joint prescription drug bill would affect their ability to purchase drugs in Canada; what can be done to get drug costs down in the U.S.; will there be cuts in other areas, such as cancer treatment; will they get kicked off other insurance plan if the government provides better coverage under Medicare?

Larsen voted against the House version of legislation this June aimed at providing prescription drug care under Medicare, calling it a “‘63 VW Beetle” of a plan. Or as one senior audience member said, “The House plan stinks.”

Larsen told the group he voted against the House proposal because it “threatens to privatize Medicare, fails to provide an affordable and straightforward benefit to seniors, and fails to rein in the high cost of prescription drugs.”

Larsen outlines drug benefit plan

In a tag board presentation he outlined his drug benefit wish list as being:

Available to all: The plan must provide coverage for all seniors and disabled Americans no matter where they live, rural or urban.

Affordable: It must have affordable premiums, a reasonable deductible and must significantly reduce the price of prescription drugs.

Guaranteed: It must have real guaranteed, defined benefits, with no huge gaps in coverage.

Within the Medicare program: Larsen favors a plan that is not separate and privatized, forcing seniors into HMOs.

In comparing the House and Senate prescription drug bills, Larsen said while the House bill pays 20 percent of drug costs up to $2,000, after a $250 deductible, the Senate bill pays 50 percent of costs up to $4,500, after a $275 deductible. With the House bill there is a gap in coverage until drug costs go over $4,900, then Medicare pays 100 percent. With the Senate bill there is a gap until costs go over $5,813, then Medicare pays 90 percent.

Larsen passed out doughnut holes to illustrate a feature of both bills called the “doughnut hole.” Under the House bill seniors continue to pay a monthly premium plus 100 percent of drug costs from $2,001 to $4,900. The Senate bill has seniors paying a monthly premium and 100 percent of drug costs from $4,501 to $5,814. Larsen said 47 percent of all Medicare beneficiaries would fall into the House “doughnut hole,” while 12 percent would be in this category under the Senate bill.

Most dramatically, the House plan “changes Medicare as we know it,” Larsen said. Under the House plan, in 2010 Medicare will be forced to compete with private plans such as HMOs, and seniors who stay in traditional Medicare could face premiums as much as 25 percent higher. The Senate version does not have a similar provision.

Seniors pay more in Island County

The high cost of prescription drugs in the United States was foremost on the minds of the assembled seniors.

Larsen presented a report he had commissioned which showed seniors in his district pay “far more” for prescription drugs than seniors in six other countries: Canada, France, Germany, Italy, Japan and the United Kingdom. For example, a monthly supply of the cholesterol-reducing drug Zocor costs $129.53 here, while in France the same drug is $37.20. Closer to home, a one year prescription of Prevacid purchased in the United States costs almost $1,000 more than the same prescription in Canada.

Some seniors in Island County have resorted to traveling to Canada to get their prescriptions filled, although technically it is illegal.

“No responsible elected official wants to arrest seniors going to Canada to buy drugs,” Larsen assured the group.

Larsen cited the government’s ability to regulate and reduce the price of drugs when they have to.

“It seems to me that if they can regulate the price of Cipro during the anthrax scare, they can regulate them for seniors with health concerns every day,” he said.

Both the House and Senate bills prohibit the Secretary of Health and Human Services from negotiating lower drug prices. That fact didn’t sit well with any of the seniors, who challenged what one senior called the “stupid rich pharmaceuticals” to lower their prices to an affordable level.

Larsen reminded them that many seniors are living healthy lives because of pharmaceutical companies, but that Congress was working to balance research and development costs with affordability.

“I don’t believe we have achieved that with these bills,” he said.

What Larsen called a major flaw of the House bill was brought up by senior Richard Anable, who called himself a cancer victim. Anable said hidden in the House bill were provisions to reduce funding for cancer treatments, such as chemotherapy and cancer care centers.

“It makes no sense,” Anable said.

Larsen agreed. “That’s wrong,” he said, “and it’s why I voted against it.”

Larsen urged those in attendance to talk to others, and let their representatives in Congress know how they feel.

The House and Senate could come up with a compromise Medicare prescription drug bill by September.

You can reach News-Times reporter Marcie Miller at or call 675-6611

We encourage an open exchange of ideas on this story's topic, but we ask you to follow our guidelines for respecting community standards. Personal attacks, inappropriate language, and off-topic comments may be removed, and comment privileges revoked, per our Terms of Use. Please see our FAQ if you have questions or concerns about using Facebook to comment.
blog comments powered by Disqus

Read the Oct 26
Green Edition

Browse the print edition page by page, including stories and ads.

Browse the archives.

Friends to Follow

View All Updates